Martin Deterre

Martin Deterre is a declared insider of Theraclion (chief executive), with filings sourced from AMF. Between 15 November 2023 and 13 May 2026, the trades on record add up to 5 filings.

On the market, this insider has only ever bought: 2 purchases. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants and 1 option exercise. 2026 to date brings 1 purchase and no sales.

The latest filing, published on 14 May 2026, reports an option exercise of €3,034 in Theraclion. The clock since the last published purchase (17 April 2026) now reads 183 days. Filings reach the AMF feed a median of 4 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.